Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 6,600 shares at $145.49 ($945K) on 2021-01-25, disclosed to the SEC on 2021-01-26.
Open-market sale of $945k MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.24 | 200 | $28K | 2.9% |
| 2 | $139.46 | 200 | $28K | 3.0% |
| 3 | $140.94 | 800 | $113K | 11.9% |
| 4 | $141.87 | 400 | $57K | 6.0% |
| 5 | $143.27 | 1,600 | $229K | 24.3% |
| 6 | $143.27 | 1,600 |
| $229K |
| 24.3% |
| 7 | $144.19 | 800 | $115K | 12.2% |
| 8 | $145.49 | 600 | $87K | 9.2% |
| 9 | $146.65 | 400 | $59K | 6.2% |
| Total | $143.15 avg | 6,600 | $945K | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |